Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-24-000085
Filing Date
2024-08-07
Accepted
2024-08-07 11:38:05
Documents
35
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT - JUNE 30, 2024 bfnh20240630_10q.htm   iXBRL 10-Q 275761
2 CHIEF EXECUTIVE OFFICER ex311.htm EX-31.1 4766
3 CHIEF FINANCIAL OFFICER ex312.htm EX-31.2 4960
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex321.htm EX-32.1 2078
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex322.htm EX-32.2 1982
11 GRAPHIC bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-24-000085.txt   1467833

Data Files

Seq Description Document Type Size
6 XBRL CALCULATION FILE bfnh-20240630_cal.xml EX-101.CAL 18816
7 XBRL DEFINITION FILE bfnh-20240630_def.xml EX-101.DEF 19312
8 XBRL LABEL FILE bfnh-20240630_lab.xml EX-101.LAB 103404
9 XBRL PRESENTATION FILE bfnh-20240630_pre.xml EX-101.PRE 74955
10 XBRL SCHEMA FILE bfnh-20240630.xsd EX-101.SCH 11039
37 EXTRACTED XBRL INSTANCE DOCUMENT bfnh20240630_10q_htm.xml XML 90973
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 241182373
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)